tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

GERN Stock Latest News

Geron Announces Executive Leadership Transitions
Company AnnouncementsGeron Announces Executive Leadership Transitions
1d ago
8K
GERN
Geron COO Andrew Grethlein, CCO Jim Ziegler to depart
PremiumThe Fly
Geron COO Andrew Grethlein, CCO Jim Ziegler to depart
2d ago
GERN
Geron Corporation’s Phase 3 Study on Imetelstat: A Potential Game-Changer for Myelofibrosis Treatment
PremiumCompany Announcements
Geron Corporation’s Phase 3 Study on Imetelstat: A Potential Game-Changer for Myelofibrosis Treatment
2M ago
GERN
Geron Corporation’s Phase 3 Study on Imetelstat: A Potential Game-Changer for Myelofibrosis Treatment
PremiumCompany Announcements
Geron Corporation’s Phase 3 Study on Imetelstat: A Potential Game-Changer for Myelofibrosis Treatment
2M ago
GERN
Geron Corporation’s Phase 3 Study: A Potential Game-Changer for Myelofibrosis Treatment
PremiumCompany Announcements
Geron Corporation’s Phase 3 Study: A Potential Game-Changer for Myelofibrosis Treatment
2M ago
GERN
Geron Inc.: Buy Rating Affirmed Amid Promising Leadership and Growth Prospects
PremiumRatingsGeron Inc.: Buy Rating Affirmed Amid Promising Leadership and Growth Prospects
2M ago
GERN
Positive Momentum and Strategic Leadership Drive Buy Rating for Geron Amid Growing Demand for Rytelo
Premium
Ratings
Positive Momentum and Strategic Leadership Drive Buy Rating for Geron Amid Growing Demand for Rytelo
2M ago
GERN
Geron Corporation Reports Strong Q2 2025 Results
Premium
Company Announcements
Geron Corporation Reports Strong Q2 2025 Results
2M ago
GERN
Geron Corporation’s Earnings Call Highlights Growth and Challenges
PremiumCompany Announcements
Geron Corporation’s Earnings Call Highlights Growth and Challenges
2M ago
GERN
Geron Appoints Harout Semerjian as New CEO
PremiumCompany Announcements
Geron Appoints Harout Semerjian as New CEO
2M ago
8K
GERN
Strong Rytelo Sales and Leadership Changes Drive Buy Rating for Geron
PremiumRatings
Strong Rytelo Sales and Leadership Changes Drive Buy Rating for Geron
2M ago
GERN
Geron’s Positive Trajectory and Strategic Growth Justify Buy Rating
PremiumRatings
Geron’s Positive Trajectory and Strategic Growth Justify Buy Rating
2M ago
GERN
Geron Inc. Hold Rating: Navigating Revenue Growth and Market Challenges
PremiumRatingsGeron Inc. Hold Rating: Navigating Revenue Growth and Market Challenges
2M ago
GERN
Geron appoints Harout Semerjian as CEO
Premium
The Fly
Geron appoints Harout Semerjian as CEO
2M ago
GERN
Geron reports Q2 EPS (2c), consensus (3c)
Premium
The Fly
Geron reports Q2 EPS (2c), consensus (3c)
2M ago
GERN
GERN Earnings this Week: How Will it Perform?
PremiumPre-Earnings
GERN Earnings this Week: How Will it Perform?
2M ago
GERN
Cautiously Optimistic: Geron’s Strategic Changes and Growth Prospects Support Buy Rating
PremiumRatings
Cautiously Optimistic: Geron’s Strategic Changes and Growth Prospects Support Buy Rating
3M ago
GERN
Geron resumed with a Sell at Goldman Sachs
PremiumThe Fly
Geron resumed with a Sell at Goldman Sachs
3M ago
GERN
Geron Corp’s Rytelo Faces Market Challenges and Declining Physician Adoption, Supporting Sell Rating
PremiumRatings
Geron Corp’s Rytelo Faces Market Challenges and Declining Physician Adoption, Supporting Sell Rating
3M ago
GERN
Geron Approves Key Proposals at Annual Meeting
PremiumCompany AnnouncementsGeron Approves Key Proposals at Annual Meeting
5M ago
8K
GERN
GERN Lawsuit Alert! Class Action Lawsuit Against Geron Corporation
Premium
Market News
GERN Lawsuit Alert! Class Action Lawsuit Against Geron Corporation
5M ago
GERN
Geron price target lowered to $6 from $7 at Wedbush
Premium
The Fly
Geron price target lowered to $6 from $7 at Wedbush
5M ago
GERN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >